This site is intended for healthcare professionals only
LoginRegister
Dr Reddy gets CDSCO Panel nod for oral semaglutideDr Reddy's Denosumab Biosimilar AVT03 Faces USFDA Setback After Plant Inspection
After 40 Years, USFDA Approves Vanda Pharmas Motion Sickness Drug NereusAfter 40 Years, USFDA Approves Vanda Pharma's Motion Sickness Drug Nereus
Pfizer, TevaPfizer Slapped With Rs 8.79 Cr GST Demand Over Alleged ITC Irregularities, Plans Appeal
Sun Pharma Rules Out Big-Bang Acquisitions, Bets on Organic Growth and BiosimilarsSun Pharma Gets CDSCO Panel Nod to Market Semaglutide Injection in Weight Loss Indication
Cough syrup racket: Rs 38 crore assets of wanted accused under scannerSonbhadra police announce reward of Rs 25,000 each on 4 in codeine syrup trafficking case
Jubilant Generics invests Rs 20 lakh in Jubilant Pharma CanadaJubilant Generics invests Rs 20 lakh in Jubilant Pharma Canada
Wockhardt posts profit of Rs 82 crore in Q2Wockhardt WCK 5222 granted accelerated assessment by EMA
Unrestricted Antibiotic Sales via E-Pharmacies: AIOCD Flags AMR Risk, Seeks PM Modis InterventionUnrestricted Antibiotic Sales via E-Pharmacies: AIOCD Flags AMR Risk, Seeks PM Modi's Intervention
GeneSys Biologics Gets SEC Nod to Market Insulin Glargine, Phase IV Study MandatedGeneSys Biologics Gets SEC Nod to Market Insulin Glargine, Phase IV Study Mandated
CDSCO Panel Seeks Revised Phase IV Trial Protocol for MSN Labs Nelarabine InjectionCDSCO Panel Seeks Revised Phase IV Trial Protocol for MSN Lab's Nelarabine Injection
Breaking News: Health Ministry Bans Immediate-Release Nimesulide Oral Doses Above 100 mgBreaking News: Health Ministry Bans Immediate-Release Nimesulide Oral Doses Above 100 mg
Indias nutraceutical sector set to grow tenfold over pharmaceuticals: FSSAI officialPrice war in China weight loss market: Novo Nordisk, Eli Lilly slash prices of Wegovy, Mounjaro
X